July 21, 2024
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

Amgen releases 4th quarter earnings


Amgen shares took a hit Jan. 30, as the company reported declines in sales and its bottom line and delivered a muted outlook for 2020. The Thousand Oaks-based biotech giant cited encroachment from biosimilars and generics as the reason behind a 1 percent dip in sales for the fourth quarter to $6.2 billion. Overall in…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.